Cidara Therapeutics (CDTX) Tops Q3 EPS by 21c

Cidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($0.73), $0.21 better than the analyst estimate of ($0.94).

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood prices $2B convertible notes offering due 2029
• Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs